GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bridge Biotherapeutics Inc (XKRX:288330) » Definitions » Credit Losses Provision

Bridge Biotherapeutics (XKRX:288330) Credit Losses Provision


View and export this data going back to 2019. Start your Free Trial

What is Bridge Biotherapeutics Credit Losses Provision?

Credit Losses Provision only applies to banks.


Bridge Biotherapeutics Business Description

Traded in Other Exchanges
N/A
Address
58, Pangyo - ro, Gyeonggi No. 303, 255 beongil Seas Tower in Bundang Pangyo, Seongnam-si, KOR, 13486
Bridge Biotherapeutics Inc is a drug research and development company. It operates in the pharmaceutical and bio industry. The company has two pipeline clinical-stage products namely, BBT-401 and BBT-877.